Research Reports for JPMorgan, Aetna, Akamai Technologies, EnCana, American International Group, and Taiwan Semiconductor

2012-04-27 20:55 638

VANCOUVER, British Columbia, April 27, 2012 /PRNewswire-Asia/ -- has issued insider trading reports and Equity Research for the following companies: JPMorgan (NYSE:JPM), Aetna (NYSE:AET), Akamai Technologies (NASDAQ:AKAM), EnCana (NYSE:ECA), American International Group (NYSE:AIG), and Taiwan Semiconductor (NYSE:TSM).

(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)

Report Highlights:

JPMorgan Chase & Co. (NYSE:JPM): JPMorgan Chase & Co.'s (NYSE:JPM) Treasury Services lately launched its mobile application Image Deposit Direct® Mobile (IDD Mobile) that enables U.S.-based companies to make check deposits using any Apple iPhone® device, instead of visiting a branch. In addition, Jeff Urwin, Head of Global Investment Banking Coverage, Capital Markets and Mergers & Acquisitions, has recently added an additional role as CEO of Asia Pacific, based in Hong Kong. JPMorgan shares closed higher by 1.48% to US$43.80 with more than 28.05 million shares traded, compared to its average volume 34.32 million shares. The company has a market capitalization of 167.40 billion. Are insiders starting to take huge profits by selling shares or exercising stock options? Academic studies have shown that insiders traditionally make higher investment returns than ordinary investors. Want to find out how they do it?

Read Full Report:

Aetna Inc. (NYSE:AET): Aetna Inc. (NYSE:AET) reported a first quarter 2012 net income of US$511.0 million, compared with a net income of US$586.0 million in the prior-year quarter. The company said its revenues increased to US$8.86 billion, from US$8.35 billion a year ago. Recently, Aetna Inc. extended its contract with WakeMed Health & Hospitals for three years. This contract will take effect on May 1, 2012. By the end of Thursday's trading, Aetna tumbled 8.21% to US$45.31. There were 17.61 million stock shares traded, which was 4.7 times more than average volume. Do you want to know when company insiders will buy their shares? Want to add and monitor this company on an on-going basis? It can be done for free by registering below.

Read Full Report:

Akamai Technologies, Inc. (NASDAQ:AKAM): found Market Option Sale (Planned) made by company President, Chief Executive Officer, Director -- Paul Sagan on April 19, at stock price US$38.27. Disclose date: April 19. In GAAP based, Akamai Technologies, Inc. (NASDAQ:AKAM) reported net income of US$43 million, or US$0.24 per diluted share, in the first quarter of 2012. This is compared with US$51 million, or US$0.26 per diluted share, in the prior-year quarter. The company said its first quarter revenue was increased by 16% to US$319 million, from US$276 million in the same quarter of 2011. Abnormal trading volume of Akamai Technologies, Inc. was found on April 26, reaching 17.40 million shares, 7 times heavier than usual day trading. The stock dropped sharply by 14.45% to US$33.15. Why? Did insiders like CEOs, CFOs, and Directors sell their shareholdings before the stock price dropped? Check out the insider trade report here.

Read Full Report:

Today also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.

EnCana Corporation (USA) (NYSE:ECA):
Read Full Report:

American International Group, Inc. (NYSE:AIG):
Read Full Report:

Taiwan Semiconductor Mfg. Co. Ltd. (ADR) (NYSE:TSM):
Read Full Report:

Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.

About covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore. features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.

Important Disclaimer:
Please visit for details.